FindMyKOL

Ashley Feneran, DO

Basic profile

Dermatology

ORCIDNone on fileNPI↗
✓ Itemized record
RegionWheaton, IL · MidwestSpecialtyDermatologyFocusDermatology
Active KOLFindMyKOL type: RegionalLatest publication2019Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ashley Feneran is a Dermatology physician. OpenAlex indexes 22 publications with 475 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22publications

Publications indexed by OpenAlex. Counts exclude supporting files.

475citations

Citations across these publications.

11h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    36.6%
    Azole Antifungal22.2%
    Ketoconazole100%
    Part D≥65 patients
    Tetracycline-class Drug7.3%
    Doxycycline Hyclate100%
    Part D≥20 patients

    + 2 more classes in this area

  • Sensory organs

    23.4%
    Corticosteroid23.4%
    Betamethasone Diprop Augmented47%Clobetasol Propionate40%Hydrocortisone13%
    Part D≥40 patients
  • Dermatology

    21.3%
    Corticosteroid13.3%
    Triamcinolone Acetonide100%
    Part D≥62 patients
    Interleukin-4 Receptor alpha Antagonist4.5%
    Dupixent Pen100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”